Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response
<p><strong>Objectives</strong> We aimed to determine whether changes in acute severe colitis (ASC) management have translated to improved outcomes and to develop a simple model predicting steroid non-response on admission.</p> <p><strong>Design</strong> Out...
主要な著者: | Adams, A, Gupta, V, Mohsen, W, Chapman, TP, Subhaharan, D, Kakkadasam Ramaswamy, P, Kumar, S, Kedia, S, McGregor, CG, Ambrose, T, George, BD, Palmer, R, Brain, O, Walsh, A, Ahuja, V, Travis, S, Satsangi, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
BMJ Publishing Group
2022
|
類似資料
-
Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic
著者:: McGregor, CG, 等
出版事項: (2021) -
DEPTH OF REMISSION MAY NOT PREDICT OUTCOME OF UC OVER 2 YEARS
著者:: Burger, D, 等
出版事項: (2011) -
Predicting outcome in acute severe colitis-controversies in clinical practice in 2021
著者:: Gupta, V, 等
出版事項: (2021) -
Development of an index that predicts escalation of therapy at an outpatient appointment in patients with known ulcerative colitis (UC)
著者:: Walsh, A, 等
出版事項: (2018) -
TrueColours ulcerative colitis (TCUC): Will patients with UC complete digital questionnaires in real-time?
著者:: Walsh, A, 等
出版事項: (2018)